Cloud Computing for Life Science Research: AWS, Google Cloud, and HPC—Which Do You Need?
AWS, Google Cloud, or institutional HPC for life science research: a practical guide to choosing the right fit.
Cloud computing life science research decisions rarely come down to a single obvious answer, because Amazon Web Services (AWS), Google Cloud, and institutional high-performance computing (HPC) each solve a different version of the same problem. A genomics core facility processing terabytes of sequencing data has different constraints than a single lab running occasional imaging analysis, and the right infrastructure choice depends heavily on data scale, budget structure, and compliance requirements rather than which platform has the most features.
Key takeaways
- Cloud computing suits research with variable, unpredictable, or rapidly scaling compute needs, while institutional HPC often works better for steady, predictable workloads.
- AWS and Google Cloud both offer genomics-specific services and government-negotiated academic pricing through National Institutes of Health (NIH) programs, but they differ in ecosystem maturity and default tooling.
- Institutional HPC eliminates ongoing subscription costs but requires upfront capital investment and carries capacity limits during peak demand.
- Data security and compliance obligations, including the need for a business associate agreement under the Health Insurance Portability and Accountability Act (HIPAA), apply whenever human subject data moves to a commercial cloud service provider (CSP).
- Moving a first bioinformatics workflow to the cloud is more manageable when scoped narrowly, starting with a single pipeline rather than a full lab migration.
When you need cloud computing for life science research
Cloud computing earns its cost when a lab's computational demand is irregular, when a single project temporarily needs far more capacity than a lab normally uses, or when collaborators at different institutions need shared access to the same dataset without shipping hard drives. A single-cell RNA sequencing project that needs a large burst of extra computing capacity for a short stretch and then little or nothing for weeks afterward is a textbook case for elastic cloud resources rather than a fixed local cluster sized for a peak that only happens occasionally.
The calculus changes for labs running continuous, predictable computation, such as a core facility that processes a steady stream of sequencing runs every week of the year. In that scenario, institutional HPC or a dedicated on-premises cluster can be more economical over several years, since the lab is not paying a premium for the elasticity it does not need. Cloud computing life science research decisions are ultimately workload-shaped: bursty, collaborative, or unpredictable work tends to favor commercial cloud, while steady, high-volume work tends to favor fixed local infrastructure, and many labs end up using both depending on the project.
NIH has recognized this pattern at scale. Through a dedicated cloud-access program for research computing, NIH-funded researchers can access negotiated academic cloud pricing with commercial CSPs rather than each lab negotiating its own contract, which meaningfully lowers the barrier to trying cloud computing for a specific project before committing to it as permanent infrastructure.
AWS for life sciences
AWS offers an extensive set of genomics-oriented cloud services, including managed batch computing and storage tiers designed for the access patterns typical of sequencing data, where files are written once and read repeatedly during analysis. Its scale and maturity mean many published bioinformatics pipelines and workflow managers already include documented AWS deployment paths, which reduces the setup effort for a lab adopting cloud computing for the first time.
That maturity comes with a corresponding depth of configuration options, which can be a double-edged sword for a research scientist without dedicated cloud engineering support. A lab moving a single genomics pipeline to AWS typically benefits from starting with a managed, higher-level service rather than assembling infrastructure from individual components, since the latter approach demands more hands-on systems administration than many research groups can sustain alongside their scientific work.
Cost management is the recurring practical challenge with AWS and with commercial cloud generally. Data storage, data egress, and compute time are billed separately, and a workflow that repeatedly downloads large reference datasets or transfers results between regions can accumulate costs that are not obvious from list pricing alone. Labs new to AWS benefit from setting billing alerts before running a large job, not after.
Google Cloud genomics and life sciences
Google Cloud offers a set of managed services oriented specifically toward genomics and life sciences, including tools for pipeline orchestration in variant calling, alignment, and other high-throughput sequencing workflows. Its life sciences tooling tends to integrate closely with widely used open-source workflow languages, which makes it a common choice for labs already using containerized, portable analysis pipelines.
Google Cloud's storage and compute pricing model is broadly comparable to AWS, and the more consequential difference for many life science researchers is less about raw pricing and more about which platform a lab's existing workflow ecosystem was built around. A team using a workflow manager with strong Google Cloud documentation and community support will generally have an easier onboarding experience there than forcing the same pipeline onto an unfamiliar platform for a marginal cost difference.
Google Cloud also participates in the same NIH-negotiated pricing framework that applies to AWS, so eligible NIH-funded investigators can access discounted rates through the same institutional enrollment process regardless of which platform ultimately fits the workflow better. That parity means the platform decision should rest primarily on workflow compatibility and existing team expertise rather than on price alone.
Institutional HPC vs cloud computing for bioinformatics
Institutional HPC clusters remain a common computing environment at research universities, and for good reason: the upfront capital cost is typically absorbed by the institution rather than an individual grant, and researchers with steady, high-volume computational needs get predictable access without a running subscription bill. A lab that already has HPC access and a workload that fits within available capacity often has little practical reason to move to commercial cloud at all.
The trade-offs become visible at the margins. HPC queue times can stretch during periods of high institutional demand, such as grant deadline season, when many labs compete for the same fixed pool of nodes. Commercial cloud sidesteps this entirely by provisioning additional capacity on demand, at a price, which is precisely the elasticity advantage that makes cloud computing attractive for projects with irregular or urgent computational spikes.
Figure 1: A four-step decision flowchart guiding researchers through choosing between commercial cloud and institutional HPC based on workload pattern, compliance needs, and tooling fit. Credit: AI-generated image created using Google Gemini (2026).
A peer-reviewed evaluation of serverless cloud architectures for CRISPR-Cas9 guide RNA design found that serverless cloud computing that scales automatically and runs only when needed can meaningfully lower the barrier to HPC for researchers who run large-scale analyses infrequently, without requiring specialized hardware or dedicated technical expertise. That finding reflects a broader trend: the gap between what commercial cloud and institutional HPC can each offer a working researcher has narrowed as managed, low-maintenance cloud services have matured.
Table 1: A qualitative comparison of AWS, Google Cloud, and institutional HPC across factors relevant to life science research computing.
| Factor | AWS | Google Cloud | Institutional HPC |
| Cost structure | Pay per use, billed for storage, compute, and data egress separately | Pay per use, comparable billing model to AWS | Largely fixed institutional cost, minimal per-project billing |
| Best fit for | Bursty or unpredictable workloads, broad ecosystem support | Genomics pipeline orchestration, workflow language integration | Steady, high-volume, predictable computational workloads |
| Setup effort | Moderate to high without managed services | Moderate, benefits from workflow manager integration | Low if institutional access already exists |
| Capacity limits | Effectively unlimited, subject to cost | Effectively unlimited, subject to cost | Fixed by institutional hardware and queue demand |
| NIH pricing access | Available through NIH-negotiated programs | Available through NIH-negotiated programs | Not applicable |
Cloud computing data security and compliance
Moving research data to a commercial CSP introduces compliance obligations that do not exist with a purely local, on-premises setup, particularly for any project involving human subject data. Under HIPAA, a covered entity or business associate that uses a CSP to create, receive, maintain, or transmit electronic protected health information must have a signed business associate agreement (BAA) with that CSP, a requirement that federal HIPAA guidance confirms applies even when data is stored in encrypted form without the CSP holding a decryption key. A lab handling clinical or patient-linked data cannot assume that encryption alone satisfies this obligation.
The National Institute of Standards and Technology (NIST) definition of cloud computing describes the essential characteristics that distinguish cloud services, including on-demand self-service and rapid elasticity, and understanding these characteristics helps a lab correctly classify what kind of cloud arrangement it is entering into and which security obligations attach to it. Public, private, hybrid, and community cloud configurations carry different risk profiles, and the appropriate BAA and risk analysis depend on which configuration a lab actually uses.
How Agentic AI Is Transforming the Modern Lab
This whitepaper examines how agentic AI is reshaping laboratory operations and what this shift means for the future of scientific discovery.View Whitepaper
Beyond HIPAA, NIH-funded researchers generating genomic or other scientific data face separate obligations under the NIH data sharing policy, which requires a documented plan for how data, including data processed or stored in the cloud, will be managed and eventually shared. A landscape analysis of cloud platforms found that data governance practices, including user authentication tiers and auditing requirements, vary meaningfully across NIH-supported platforms, which means a lab cannot assume the same compliance posture applies uniformly across every cloud-based genomic data resource it might use. Getting these obligations organized before data ever leaves the lab, rather than after a project is already underway, avoids a compliance scramble later. This kind of upfront planning connects directly to structuring experimental data properly long before any cloud migration begins.
Getting started with cloud computing for research
Moving a first workflow to the cloud goes more smoothly when a lab treats it as a scoped pilot rather than a wholesale infrastructure change. A single, well-understood pipeline, run once on a modest dataset, surfaces the practical friction points, including cost surprises and configuration gaps, before a lab commits a larger project to the same setup.
A practical sequence for a first cloud migration looks like the following:
- Select one existing, well-documented pipeline rather than a novel or exploratory analysis, since known expected outputs make it easier to confirm the cloud run produced correct results.
- Choose the platform based on where the pipeline's workflow manager already has strong documentation and community support, rather than defaulting to whichever platform is most familiar from outside research contexts.
- Set a cost alert or budget cap before running the job, since unexpected cloud billing is a common source of first-migration frustration.
- Run the pipeline on a subset of the full dataset first to validate correctness and estimate cost per sample before scaling to the complete dataset.
- Document the configuration once it works, since the setup effort for a second, similar pipeline drops substantially once a working template exists.
Labs already running structured, well-tagged data capture through a laboratory information management system tend to have an easier time with this migration, since consistently captured metadata and sample records translate more directly into a cloud pipeline's expected inputs than data scattered across spreadsheets and lab notebooks.
Choosing the right cloud computing for life science research
The right answer to AWS versus Google Cloud versus institutional HPC is rarely a single platform for every project a lab runs. Bursty, collaborative, or urgently scaled work tends to favor commercial cloud, steady high-volume work tends to favor institutional HPC where it is available, and many labs end up running a genuinely mixed environment that shifts by project rather than settling on one platform permanently.
What matters more than the specific platform choice is treating cloud computing life science research decisions as an infrastructure question with real compliance and cost stakes, not a default upgrade. The growing role of cloud computing in biology and genomics research means a lab that scopes its first migration narrowly, checks its compliance obligations before data moves anywhere, and picks a platform based on actual workflow fit will get more durable value than one that adopts cloud infrastructure because it seems like the modern option. These infrastructure decisions increasingly sit alongside the broader shift toward applying computational tools broadly across the research pipeline, where the underlying compute environment shapes what is practically possible long before any specific analysis begins.
This content includes text that has been created with the assistance of generative AI and has undergone editorial review before publishing. Technology Networks' AI policy can be found here.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
